Author(s)
Mihir P. Torsekar
This article discusses China’s transition towards higher-value-added segments of the medical device global value chain (GVC) as observed through changes in both the composition of foreign direct investment (FDI) and in the technological complexity of its medical device exports. The period under review is primarily 2003–17.